data (Page 14)

Md Saiful Islam Khan/iStock via Getty Images Annexon (NASDAQ:ANNX) shares traded higher on Wednesday after the company released additional data from its completed pivotal Phase 3 trial for its lead asset, ANX005, against the neurological disorder Guillain-Barré syndrome (GBS). Early this month, citing topline results from the study, the Brisbane,Continue Reading

Pgiam/iStock via Getty Images Oppenheimer downgraded respiratory device maker ResMed (NYSE:RMD) to Perform from Outperform on Tuesday, citing an “air pocket” for the stock in the wake of encouraging data for Eli Lilly’s (NYSE:LLY) weight loss therapy tirzepatide in obstructive sleep apnea (OSA). The maker of CPAP (continuous positive airwayContinue Reading

RomanBabakin Sanofi (NASDAQ:SNY) is up ~3% in Monday afternoon trading as it stands to benefit from positive data released earlier in the day on Alnylam Pharmaceuticals’ (ALNY) Amvuttra (vutrisiran) The data was on the drug in treating ATTR amyloidosis with cardiomyopathy. The therapoy was already approved for polyneuropathy of hereditaryContinue Reading